Determinants of blood telomere length in antiretroviral treatment‐naïve HIV ‐positive participants enrolled in the NEAT 001/ ANRS 143 clinical trial

Volume: 20, Issue: 10, Pages: 691 - 698
Published: Sep 18, 2019
Abstract
Objectives Our aim was to investigate factors associated with baseline blood telomere length in participants enrolled in NEAT 001/ANRS 143, a randomized, open-label trial comparing ritonavir-boosted darunavir (DRV/r) plus raltegravir (RAL) with DRV/r plus tenofovir disoproxil fumarate/emtricitabine (TDF/FTC) in antiretroviral therapy (ART)-naïve HIV-positive adults. Methods A cross-sectional study of 201 randomly selected participants who had...
Paper Details
Title
Determinants of blood telomere length in antiretroviral treatment‐naïve HIV ‐positive participants enrolled in the NEAT 001/ ANRS 143 clinical trial
Published Date
Sep 18, 2019
Volume
20
Issue
10
Pages
691 - 698
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.